Legal opinion of Zhong Lun Law Firm on the second interim shareholders' meeting of Aoji Medical in 2024, Peking.
Allgens Medical Technology: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Agenda for the second extraordinary shareholders' meeting of Aojing Medical in 2024.
Allgens Medical Technology: Announcement on the change of supervisors
Allgens Medical Technology: Announcement on the adjustment of investment amounts for some fund-raising projects, new fund-raising projects, and new implementing entities and implementation locations
Allgens Medical Technology: Announcement on the replacement of independent directors and relevant special committee members
Independent Director's Letter of Commitment
Allgens Medical Technology: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Allgens Medical Technology: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Aojing Healthcare
Aojing Medical 2023 Annual General Meeting of Shareholders Meeting Materials
Allgens Medical Technology: 2023 Board Audit Committee Performance Report
Allgens Medical Technology: Report on the performance of supervisory duties by the Board of Auditors on accounting firms
Allgens Medical Technology: Notice on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to issuing shares to specific targets through simple procedures
Allgens Medical Technology: Notice on convening the 2023 Annual General Meeting of Shareholders
Allgens Medical Technology: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Managers
Allgens Medical Technology: Announcement on the purchase of liability insurance for directors and supervisors
Announcement on the abolished portion of restricted shares granted that have not yet been vested
Allgens Medical Technology: Special report on the company's non-operating capital occupation and other related capital transactions
Allgens Medical Technology: 2023 Internal Control Evaluation Report
No Data